136
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Malignancy Risk Stratification Prediction of Amorphous Calcifications Based on Clinical and Mammographic Features

, , , , , ORCID Icon & show all
Pages 235-245 | Published online: 12 Jan 2021

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
  • Stomper PC, Connolly JL. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype. AJR Am J Roentgenol. 1992;159(3):483–485. doi:10.2214/ajr.159.3.13239231323923
  • Sickles EA, D’Orsi CJ, Bassett LW, et al. ACR BI-RADS mammography. In: ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. Reston, VA, American College of Radiology. 2013;61–78.
  • Oligane HC, Berg WA, Bandos AI, et al. Grouped amorphous calcifications at mammography: frequently atypical but rarely associated with aggressive malignancy. Radiology. 2018;288(3):671–679. doi:10.1148/radiol.201817240629916773
  • Kim SY, Kim HY, Kim EK, Kim MJ, Moon HJ, Yoon JH. Evaluation of malignancy risk stratification of microcalcifications detected on mammography: a study based on the 5th edition of BI-RADS. Ann Surg Oncol. 2015;22(9):2895–2901. doi:10.1245/s10434-014-4362-625608770
  • Grimm LJ, Johnson DY, Johnson KS, et al. Suspicious breast calcifications undergoing stereotactic biopsy in women ages 70 and over: breast cancer incidence by BI-RADS descriptors. Eur Radiol. 2017;27(6):2275–2281. doi:10.1007/s00330-016-4617-727752832
  • Iwase M, Tsunoda H, Nakayama K, et al. Overcalling low-risk findings: grouped amorphous calcifications found at screening mammography associated with minimal cancer risk. Breast Cancer. 2017;24(4):579–584. doi:10.1007/s12282-016-0742-z27873170
  • Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.979118323559
  • Timmers JMH, Verbeek ALM, IntHout J, et al. Breast cancer risk prediction model: a nomogram based on common mammographic screening findings. Eur Radiol. 2013;23(9):2413–2419. doi:10.1007/s00330-013-2836-823591619
  • Park HS, Kim HY, Park S, et al. A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy. Breast. 2013;22(5):869–873. doi:10.1016/j.breast.2013.03.00923601760
  • Wang H, Lai J, Li J, et al. Does establishing a preoperative nomogram including ultrasonographic findings help predict the likelihood of malignancy in patients with microcalcifications? Cancer Imaging. 2019;19(1):46. doi:10.1186/s40644-019-0229-131269987
  • Kim J, Kim EK, Kim MJ, Moon HJ, Yoon JH. “Category 4A” microcalcifications: how should this subcategory be applied to microcalcifications seen on mammography? Acta Radiol. 2018;59(2):147–153. doi:10.1177/028418511770903628490180
  • Moy L. Should we continue to biopsy all amorphous calcifications? Radiology. 2018;288(3):680–681. doi:10.1148/radiol.201818076729916774
  • Sen LQC, Huang ML, Leung JWT, Wei W, Adrada BE. Malignancy rates of stereotactic biopsies of two or more distinct sites of suspicious calcifications in women without known breast cancer. Clin Imaging. 2019;58:156–160. doi:10.1016/j.clinimag.2019.07.00731376706
  • Chai X, Sun MY, Jia HY, et al. A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery. PeerJ. 2019;7:e7837. doi:10.7717/peerj.783731632852
  • Farshid G, Sullivan T, Downey P, Gill PG, Pieterse S. Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases. Br J Cancer. 2011;105(11):1669–1675. doi:10.1038/bjc.2011.46622052156
  • Berg WA, Arnoldus CL, Teferra E, et al. Biopsy of amorphous breast calcifications: pathologic outcome and yield at stereotactic biopsy. Radiology. 2001;221(2):495–503. doi:10.1148/radiol.221201016411687695
  • Basile TMA, Fanizzi A, Losurdo L, et al. Microcalcification detection in full-field digital mammograms: a fully automated computer-aided system. Phys Med. 2019;64:1–9. doi:10.1016/j.ejmp.2019.05.02231515007
  • Fanizzi A, Basile TMA, Losurdo L, et al. A machine learning approach on multiscale texture analysis for breast microcalcification diagnosis. BMC Bioinform. 2020;21(Suppl 2):91. doi:10.1186/s12859-020-3358-4
  • Huang Y, Liu Z, He L, et al. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology. 2016;281(3):947–957. doi:10.1148/radiol.201615223427347764
  • Kattan MW. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst. 2003;95(9):634–635. doi:10.1093/jnci/95.9.63412734304
  • Yu FH, Wang JX, Ye XH, et al. Ultrasound-based radiomics nomogram: a potential biomarker to predict axillary lymph node metastasis in early-stage invasive breast cancer. Eur J Radiol. 2019;119:108658. doi:10.1016/j.ejrad.2019.10865831521878
  • Sadeghi M, Alamdaran S, Daneshpajouhnejad P, et al. A logistic regression nomogram to predict axillary lymph node metastasis in early invasive breast cancer patients. Breast J. 2019;25(4):769–771. doi:10.1111/tbj.1334031155810
  • Han L, Zhu Y, Liu Z, et al. Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer. Eur Radiol. 2019;29(7):3820–3829. doi:10.1007/s00330-018-5981-230701328
  • Gooch Jessica C, Schnabel F, Chun J, et al. A nomogram to predict factors associated with lymph node metastasis in ductal carcinoma in situ with microinvasion. Ann Surg Oncol. 2019;26(13):4302–4309. doi:10.1245/s10434-019-07750-931529311
  • Hwang HW, Jung H, Hyeon J, et al. A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients. Breast Cancer Res Treat. 2019;173(2):255–266. doi:10.1007/s10549-018-4981-x30324273
  • Pan X, Yang W, Chen Y, et al. Nomogram for predicting the overall survival of patients with inflammatory breast cancer: a SEER-based study. Breast. 2019;47:56–61. doi:10.1016/j.breast.2019.05.01531351202